Table 1.
Summary of gene polymorphisms which might impact CLZ treatment.
Gene | Variant | Genotype/Allele | Predicted Phenotype | Reference |
---|---|---|---|---|
DRD2 | rs1800497 (Taq1A) | A1/A1 or T/T *A1 allele or T allele |
Better response CLZ | [18] |
HTR2A | rs6313 (T102C) | C/C C allele |
Non-response CLZ | [20,21] |
HTR2A | rs6314 (C1354T or His452Tyr) | T/T T allele or 452Tyr |
Non-response CLZ | [26,27,28] |
SLC6A4 | rs4795541 | S/S or S allele | Non-response CLZ | [29] |
SLC6A4 | rs25531 | G/G or G allele | Non-response CLZ | [29] |
CYP1A2 | rs7625521 | *1F/*1F or A/A A or *1F allele |
Low CLZ plasma and non-response | [33] |
ABCB1 | rs1045642 (C3435T) | T/T or T allele | High CLZ plasma and better response | [34] |
ABCB1 | rs2032582 (G2677T) | T/T or T allele | High CLZ plasma and better response | [34] |